Suppr超能文献

甲状腺癌患者的获益发现及其影响因素:一项回顾性研究。

Benefit finding and its influencing factors in patients with thyroid cancer: A retrospective study.

作者信息

Qian Yingjia, Zheng Lei, Li Jian

机构信息

School of Nursing, Shanghai Jiao Tong University, Shanghai, China.

Department of Nursing, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

Asia Pac J Oncol Nurs. 2024 Sep 6;11(11):100584. doi: 10.1016/j.apjon.2024.100584. eCollection 2024 Nov.

Abstract

OBJECTIVE

To understand the level of benefit finding in patients with thyroid cancer and identify its influencing factors.

METHODS

This retrospective study included 241 patients with thyroid cancer who underwent surgical treatment at a tertiary hospital in Shanghai from October to December 2022. Data were collected using the General Information Questionnaire, the Chinese Benefit Finding Scale, the Social Support Revalued Scale, and the Medical Coping Modes Questionnaire. Logistic regression analysis was performed to explore factors influencing benefit finding.

RESULTS

The total benefit finding score among patients with thyroid cancer was 89.00 (76.00, 101.50). Logistic regression analysis indicated that social support (OR = 1.08, 95% CI: 1.02-1.14) and avoidance coping mode (OR = 1.17, 95% CI: 1.00-1.37) significantly impacted benefit finding ( < 0.05).

CONCLUSIONS

Patients with thyroid cancer demonstrated a high level of benefit finding. Social support and medical coping modes were identified as key factors influencing benefit finding. Healthcare professionals should focus on enhancing these aspects to improve benefit finding in patients with thyroid cancer.

TRIAL REGISTRATION

EC REFERENCE No. 2024-133.

摘要

目的

了解甲状腺癌患者的获益发现水平,并确定其影响因素。

方法

本回顾性研究纳入了2022年10月至12月在上海一家三级医院接受手术治疗的241例甲状腺癌患者。使用一般信息问卷、中文版获益发现量表、社会支持再评价量表和医学应对方式问卷收集数据。进行Logistic回归分析以探讨影响获益发现的因素。

结果

甲状腺癌患者的获益发现总得分是89.00(76.00,101.50)。Logistic回归分析表明,社会支持(OR = 1.08,95%CI:1.02 - 1.14)和回避应对方式(OR = 1.17,95%CI:1.00 - 1.37)对获益发现有显著影响(<0.05)。

结论

甲状腺癌患者表现出较高水平的获益发现。社会支持和医学应对方式被确定为影响获益发现的关键因素。医护人员应关注加强这些方面,以提高甲状腺癌患者的获益发现水平。

试验注册

EC参考编号2024 - 133。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d4b/11472082/00e06eaf6bd0/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验